p53-dependent ceramide response to genotoxic stress.
Both p53 and ceramide have been implicated in the regulation of growth suppression. p53 has been proposed as the "guardian of the genome" and ceramide has been suggested as a "tumor suppressor lipid. " Both molecules appear to regulate cell cycle arrest, senescence, and apoptosis. In this study, we investigated the relationship between p53 and ceramide. We found that treatment of Molt-4 cells with low concentrations of actinomycin D or gamma-irradiation, which activate p53-dependent apoptosis, induces apoptosis only in cells expressing normal levels of p53. In these cells, p53 activation was followed by a dose- and time-dependent increase in endogenous ceramide levels which was not seen in cells lacking functional p53 and treated similarly. Similar results were seen in irradiated L929 cells whereby the p53-deficient clone was significantly more resistant to irradiation and exhibited no ceramide response. However, in p53-independent systems, such as growth suppression induced by TNF-alpha or serum deprivation, ceramide accumulated irrespective of the upregulation of p53, indicating that p53 regulates ceramide accumulation in only a subset of growth-suppressive pathways. Finally, ceramide did not increase p53 levels when used at growth-suppressive concentrations. Also, when cells lacking functional p53, either due to mutation or the expression of the E6 protein of human papilloma virus, were treated with exogenous ceramide, there was equal growth suppression, cell cycle arrest, and apoptosis as compared with cells expressing normal p53. These results indicate that p53 is unlikely to function "downstream" of ceramide. Instead, they suggest that, in situations where p53 performs a critical regulatory role, such as the response to genotoxic stress, it functions "upstream" of ceramide. These studies begin to define a relationship between these two pathways of growth inhibition.
Dbaibo
G S
GS
Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA.
Pushkareva
M Y
MY
Rachid
R A
RA
Alter
N
N
Smyth
M J
MJ
Obeid
L M
LM
Hannun
Y A
YA
D000818:Animals; D017209:Apoptosis; D002460:Cell Line; D002518:Ceramides / Q000378:metabolism*; D003609:Dactinomycin / Q000494:pharmacology; D005069:Evaluation Studies as Topic; D005720:Gamma Rays; D018922:HL-60 Cells; D006801:Humans; D051379:Mice; D009152:Mutagenicity Tests; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
D002518:Ceramides; D016159:Tumor Suppressor Protein p53; D003609:Dactinomycin